In response to a question from the British newspaper “The Sun” about his expectations regarding the date of elimination Covid-19Jonathan explained that the disease will likely continue in humans forever, adding that infection with the virus will become “seasonal.”
and regarding Of precautionary measures Imposed due to the pandemic, Jonathan explained: “I don’t think the government will continue to recommend Social distancing Masks and hand sanitizer forever. I hope that we will return to our normal life before the outbreak of the epidemic, although I believe that some of the habits we have adopted during this period may become permanent for some. “
And about The vaccine Which the British government authorized for use and which is produced by two companies.Pfizer” And”Biontec“, Jonathan indicated the need to take two doses of it to obtain full protection, pointing out that scientists do not know whether the vaccine prevents the transmission of the virus.
Regarding the duration of the vaccination process, Jonathan indicated that it may take months, calling for the demand for vaccination with the vaccine, if citizens want to end the procedures of social distancing and the restrictions of closure.
On Wednesday, the British government agreed to use the vaccine produced by “Pfizer” and “Biontech” against the emerging corona virus.
“The recommendation of the Independent Medicines and Healthcare Products Regulatory Agency to approve the Covid-19 vaccine has been accepted by Pfizer and Biontech,” the government said in a statement.
The statement added: “The vaccine will be available throughout Britain from next week,” according to the British “Sky News” network.
“The NHS has decades of experience providing vaccination programs on a large scale, and it will work to prepare intensively to provide care and support to all those eligible for vaccination,” said the Ministry of Health and Social Care spokesman.
The two companies, “Pfizer” and “Biontech”, have applied for a license to market their vaccine against Corona in Europe.
The two groups said in a statement that they had submitted, on Monday, a request from the European Medicines Agency to “obtain a conditional license to market” their vaccine after tests showed that it was 95 percent effective against Covid-19.
And the statement said that the vaccine “will be available in Europe before the end of 2020” in the event that he obtains the necessary license, according to “AFP.”
“Pfizer” and its German partner, “Biontech”, announced a few days ago that the results of the final experiments showed that their vaccine was effective in preventing Covid-19 by 95 percent without any safety concerns.
The companies expect the US Food and Drug Administration to grant approval for emergency use by mid-December.
“Pfizer” stated that it expects to have 50 million vaccine doses ready this year, enough to protect 25 million people.
And “Pfizer” has an agreement to sell 100 million doses of its vaccine to the United States government, and gives it the option to purchase 500 million additional doses. The company is also in talks with other governments, including the European Union, about similar deals.
The two companies ’vaccine uses” mRNA “or” ribonucleic acid “technology, as it programs human cells to produce copies of part of the virus, with the aim of stimulating the immune system to attack if the real virus enters the body.
The announcement of the license application for the “Pfizer” vaccine against Covid-19 in Europe came after US media reported that the first shipments of the “Pfizer” vaccine arrived in the United States from the company’s laboratory in Belgium.
The Wall Street Journal and other media reported that Pfizer was using charter flights to pre-prepare the vaccine for rapid distribution once approved in the United States.
And the CEO of “Pfizer” Albert Burla, last month, revealed the strategies that the company will adopt to overcome the obstacles that stand in the way of its vaccine.
According to “Pfizer”, its vaccine, which contains DNA or part of the genetic code of the virus, should be stored at a temperature between minus 70 and minus 80 degrees Celsius.
During his participation in a seminar organized by the American newspaper “New York Times”, Burla said that “Pfizer” is able to ship the vaccine to most areas of the United States of America in a time not exceeding a day.
In his speech, Burla touched on a number of technical and logistical aspects related to the property, such as developing engineers at Pfizer for shipping container boxes that provide the required temperature to maintain the effectiveness of the vaccine, and they also contain a GPS system and an alarm that warns us in the event of any defect in these boxes.